In the digital era, Pharma companies must monitor online spaces for compliance or risk financial penalties. With over 85% of companies at risk for receiving financial penalties, the FDA issued over 180 warning letters in 2023 alone.
Product Resources
Pharmaceutical Compliance Overview
February 23, 2024
